The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion
- PMID: 16629415
- DOI: 10.1191/135248506ms1304rr
The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion
Abstract
Advances in the neuropathology of multiple sclerosis (MS) have contributed greatly to our understanding of the mechanisms of tissue injury in the condition. Particular interest has focussed on the active MS lesion, defined by macrophage activity in the presence of partially demyelinated axons. This has led to the prevailing consensus that a T-cell dependent, macrophage-mediated, autoimmune attack on constituents in the normal myelin sheath underlies the disease. This hypothesis, which has been largely supported by comparisons with the animal model, experimental allergic encephalomyelitis, has recently been questioned by an analysis of the pathological events preceding myelin phagocytosis in nascent MS lesions. The prephagocytic changes in evolving lesions examined shortly after the onset of an MS relapse raise the possibility that oligodendrocyte cell death and associated changes within the myelin sheath initiate local macrophage scavenger activity, with subsequent amplification of the inflammatory response. The presence of such lesions in patients with a spectrum of pathological changes in nearby or distant active phagocytic plaques suggests that pathological heterogeneity in MS is largely due to evolution of lesional pathology, rather than pathogenic heterogeneity.
Similar articles
-
Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.Ann Neurol. 2009 Dec;66(6):739-53. doi: 10.1002/ana.21800. Ann Neurol. 2009. PMID: 20035511
-
Oligodendrocytes and the early multiple sclerosis lesion.Ann Neurol. 2012 Jul;72(1):18-31. doi: 10.1002/ana.23634. Ann Neurol. 2012. PMID: 22829266 Review.
-
Macrophages in multiple sclerosis.Immunobiology. 1996 Oct;195(4-5):588-600. doi: 10.1016/S0171-2985(96)80024-6. Immunobiology. 1996. PMID: 8933159
-
MS: is it one disease?Int MS J. 2009 Jun;16(2):57-65. Int MS J. 2009. PMID: 19671369 Review.
-
Neuropathology in multiple sclerosis: new concepts.Mult Scler. 1998 Jun;4(3):93-8. doi: 10.1177/135245859800400301. Mult Scler. 1998. PMID: 9762654 Review.
Cited by
-
Myelin-derived lipids modulate macrophage activity by liver X receptor activation.PLoS One. 2012;7(9):e44998. doi: 10.1371/journal.pone.0044998. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984598 Free PMC article.
-
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Br J Pharmacol. 2011 Oct;164(4):1079-106. doi: 10.1111/j.1476-5381.2011.01302.x. Br J Pharmacol. 2011. PMID: 21371012 Free PMC article. Review.
-
Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.Int J Mol Sci. 2018 Jun 1;19(6):1639. doi: 10.3390/ijms19061639. Int J Mol Sci. 2018. PMID: 29865151 Free PMC article. Review.
-
Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.PLoS One. 2013 Oct 16;8(10):e76359. doi: 10.1371/journal.pone.0076359. eCollection 2013. PLoS One. 2013. PMID: 24146858 Free PMC article.
-
Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.PLoS One. 2015 Jul 21;10(7):e0133916. doi: 10.1371/journal.pone.0133916. eCollection 2015. PLoS One. 2015. PMID: 26196511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical